在肠道瘤启动模型中定义干细胞动态
Louis Vermeulen1, Edward Morrissey, Maartje van der Heijden
1Cancer Research UK, Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.
概括
癌细胞突变提供了竞争优势,但它们的优势并不总是决定性的. 肠道组织结构和随机事件可以抑制突变细胞系的生长,特别是在大肠炎中的P53突变.
科学领域:
- * 分子生物学 * 分子生物学
- * 发育生物学 发育生物学
- * 癌症研究研究
背景情况:
- * 癌症是由细胞中积累的遗传异常引起的.
- * 在瘤发育过程中常见突变的定量益处尚不清楚.
- * 了解克隆动态对于了解癌症进展至关重要.
研究的目的:
- * 量化小鼠肠道中特定突变 (Apc损失,Kras激活,P53突变) 的竞争优势.
- * 调查随机事件和组织架构在抑制突变血统中的作用.
- * 探索突变的条件依赖优势,特别是P53,在特定的疾病环境中,如结肠炎.
主要方法:
- * 利用小鼠模型研究肠道干细胞动力学.
- *量化了Apc损失,Kras激活和P53突变所带来的竞争优势.
- *分析了肠道组织结构中的克隆替代和血统抑制.
主要成果:
- * 发现像Apc丢失,Kras激活和P53突变这样的突变不会决定细胞命运.
- * 证明突变干细胞可以通过有偏见的随机事件被野生类型干细胞取代.
- *确定了P53突变的条件依赖优势,特别是在大肠炎影响的肠道中显著增强.
- * 证实肠道组织结构抑制了突变血统的积累.
结论:
- *常见癌症突变的竞争优势取决于环境,并受到随机过程的影响.
- *肠道组织结构在调节突变细胞群的扩张方面发挥着重要作用.
- * P53突变在炎症条件中表现出特定的优势,突出突变与微环境之间的相互作用.
相关概念视频
Renewal of Intestinal Stem Cells
2.7K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
1.8K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance
2.0K
2.0K
Adult Stem Cells
27.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
27.9K


